• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinicopathologic roles of tumor-infiltrating lymphocytes and CD8-positive lymphocytes in lung cancer imprint smears in squamous cell carcinoma and adenocarcinoma.

作者信息

Ikeda Satoshi, Funakoshi Naoya, Inagaki Masaharu, Shibata Toshikatsu

机构信息

Department of Pathology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.

出版信息

Acta Cytol. 2006 Jul-Aug;50(4):423-9. doi: 10.1159/000325986.

DOI:10.1159/000325986
PMID:16901008
Abstract

OBJECTIVE

To investigate the presence of tumor-infiltrating lymphocytes (TILs) and CD8-positive lymphocytes (CD8s) in lung cancers and to examine the prognostic significance of their relationship with clinicopathologic parameters.

STUDY DESIGN

Primary tumor imprint smears from 83 lung cancers were consecutively obtained at surgery at Tsuchiura Kyodo General Hospital between 1996 and 1998. TILs were observed in Papanicolaou-stained smears, and CD8s were immunocytochemically visualized.

RESULTS

TILs were judged positive in 42 cases (51%), and 34 of 83 cases (41%) were positive for CD8s. There was no correlation between the frequency of TILs and CD8s. TILs assessed by Papanicolaou staining in 83 cases showed no correlation with any clinicopathologic factors. CD8s were observed more frequently in squamous cell carcinomas (SCCs) than other adenocarcinomas. A high frequency of CD8s was associated with lymph node metastasis (p = 0.043), stage (p = 0.025) and tumor differentiation (p = 0.03). TILs and CD8s made no significant difference in survival. However, in SCC the patients positive for TILs but negative for CD8s survived and had a significantly better prognosis than did the others (p = 0.037).

CONCLUSION

CD8s were associated with tumor progression and development of malignancy in lung cancers. Especially in SCC, the cases had a high frequency of TILs. A low number of CD8s may correlate with a favorable prognosis.

摘要

相似文献

1
Clinicopathologic roles of tumor-infiltrating lymphocytes and CD8-positive lymphocytes in lung cancer imprint smears in squamous cell carcinoma and adenocarcinoma.
Acta Cytol. 2006 Jul-Aug;50(4):423-9. doi: 10.1159/000325986.
2
Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.程序性细胞死亡配体1(PD-L1)、CD8 +肿瘤浸润淋巴细胞和p53在非小细胞肺癌中的预后意义:一项免疫组织化学研究
Turk Patoloji Derg. 2017;1(1):211-222. doi: 10.5146/tjpath.2017.01398.
3
Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.肺鳞状细胞癌瘤内CD103 +肿瘤浸润淋巴细胞的预后意义
Oncotarget. 2017 Feb 21;8(8):13762-13769. doi: 10.18632/oncotarget.14632.
4
Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.肿瘤浸润淋巴细胞对完全切除的IIIA期(N2)非小细胞肺癌患者的预后价值
Oncotarget. 2016 Feb 9;7(6):7227-40. doi: 10.18632/oncotarget.6979.
5
Aligning digital CD8 scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma.将数字 CD8 评分与程序性死亡配体 1 表达的靶向下一代测序相匹配:早期鳞状细胞肺癌中的实用方法。
Histopathology. 2018 Jan;72(2):270-284. doi: 10.1111/his.13346. Epub 2017 Nov 3.
6
TCR repertoire intratumor heterogeneity of CD4 and CD8 T cells in centers and margins of localized lung adenocarcinomas.局部肺腺癌中心和边缘处 CD4 和 CD8 T 细胞 TCR 库的肿瘤内异质性。
Int J Cancer. 2019 Feb 15;144(4):818-827. doi: 10.1002/ijc.31760. Epub 2018 Sep 29.
7
Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.肺鳞状细胞癌中PD-L1和PD-L2表达的临床病理分析:与肿瘤浸润性T细胞及致癌驱动因素状态的比较
Lung Cancer. 2015 Apr;88(1):24-33. doi: 10.1016/j.lungcan.2015.01.016. Epub 2015 Jan 24.
8
Density and location of CD3 and CD8 tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma.CD3 和 CD8 肿瘤浸润淋巴细胞的密度和位置与口腔鳞状细胞癌的预后相关。
J Oral Pathol Med. 2018 Apr;47(4):359-367. doi: 10.1111/jop.12698. Epub 2018 Mar 12.
9
CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.在人类非小细胞肺癌中,癌基质中的CD4+ T细胞而非癌细胞巢中的CD8+ T细胞与良好预后相关。
Cancer Sci. 2003 Nov;94(11):1003-9. doi: 10.1111/j.1349-7006.2003.tb01392.x.
10
The mechanism of de novo expression of programmed cell death-ligand 1 in squamous cell carcinoma of the lung.新表达的程序性细胞死亡配体 1 在肺鳞状细胞癌中的作用机制。
Oncol Rep. 2017 Oct;38(4):2189-2196. doi: 10.3892/or.2017.5876. Epub 2017 Aug 3.

引用本文的文献

1
Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis.肿瘤浸润淋巴细胞对非小细胞肺癌预后的影响:系统评价和荟萃分析。
Front Immunol. 2024 Sep 20;15:1476365. doi: 10.3389/fimmu.2024.1476365. eCollection 2024.
2
GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells.GPC3 促进肺鳞状细胞癌的进展和 HLA-A2 限制性 GPC3 抗原肽修饰的树突状细胞诱导的细胞毒性 T 淋巴细胞杀伤肺鳞状细胞癌细胞。
J Immunol Res. 2023 Nov 6;2023:5532617. doi: 10.1155/2023/5532617. eCollection 2023.
3
Prognostic and Therapeutic Implications of Immune Classification by CD8 Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Sinonasal Squamous Cell Carcinoma.
CD8 肿瘤浸润淋巴细胞和 PD-L1 表达的免疫分类对鼻窦鳞状细胞癌的预后和治疗意义。
Int J Mol Sci. 2021 Jun 28;22(13):6926. doi: 10.3390/ijms22136926.
4
Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.常见肿瘤浸润淋巴细胞亚型对非小细胞肺癌患者预后的价值:一项荟萃分析。
PLoS One. 2020 Nov 10;15(11):e0242173. doi: 10.1371/journal.pone.0242173. eCollection 2020.
5
Immunotherapy in Lung Cancer.肺癌中的免疫疗法。
Cancer Treat Res. 2016;170:203-23. doi: 10.1007/978-3-319-40389-2_10.
6
Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer.肿瘤浸润淋巴细胞在非小细胞肺癌患者临床治疗研究中的预后及预测价值
Oncotarget. 2016 Mar 22;7(12):13765-81. doi: 10.18632/oncotarget.7282.
7
Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma.采用重定向至磷脂酰肌醇蛋白聚糖-3的T淋巴细胞进行过继性免疫治疗以治疗肺鳞状细胞癌。
Oncotarget. 2016 Jan 19;7(3):2496-507. doi: 10.18632/oncotarget.6595.
8
Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.肿瘤内调节性T细胞水平低和肿瘤周围CD8(+) T细胞水平高与胰腺导管腺癌患者胰十二指肠切除术后的长期生存相关。
Cancer Immunol Immunother. 2016 Jan;65(1):73-82. doi: 10.1007/s00262-015-1775-4. Epub 2015 Dec 8.
9
Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy.肺鳞状细胞癌中未满足的需求:免疫疗法的潜在作用。
Med Oncol. 2014 May;31(5):960. doi: 10.1007/s12032-014-0960-1. Epub 2014 Apr 19.
10
Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma.Foxp3(+) 细胞浸润和颗粒酶 B(+) / Foxp3(+) 细胞比值与新辅助化疗治疗卵巢癌的预后相关。
Cancer Immunol Immunother. 2010 Jun;59(6):909-19. doi: 10.1007/s00262-010-0817-1. Epub 2010 Jan 20.